Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ...
Claude 3.7 Sonnet debuts with “extended thinking” to tackle complex problems
On Monday, Anthropic announced Claude 3.7 Sonnet, a new AI language model with a simulated reasoning (SR) capability called " ...
CDOTrends4d
Claude 3.7 Sonnet Takes Back the AI Crown
Based on results across various benchmarks, Claude 3.7 Sonnet is back in the lead in the white-hot race for AI supremacy, ...
Nasdaq5d
Sonnet BioTherapeutics Holdings, Inc. Announces Availability of On-Demand Video Webcast Following Virtual Investor "Top 5 for ‘25" Conference
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...
Yahoo Finance5d
Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it participated in the Virtual Investor "Top 5 for ...
The Truth About GPT-4.5: Strengths, Weaknesses and Costs
Explore key differences, creative applications, and whether the price increase is justified for your needs. Uncover GPT-4.5 ...
Bleeping Computer19d
Anthropic's Claude 3.7 Sonnet is here and results are insane
Competing models, including Claude 3.5 Sonnet and OpenAI’s variants, sit closer to the 50% range. "Software engineering (SWE-bench verified)" is a benchmarking standard to see how well an AI ...